MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes.

GLUT4 shows decreased levels in failing human adult hearts. We speculated that GLUT4 expression in cardiac muscle may be fine-tuned by microRNAs. Forced expression of miR-133 decreased GLUT4 expression and reduced insulin-mediated glucose uptake in cardiomyocytes. A computational miRNA target prediction algorithm showed that KLF15 is one of the targets of miR-133. It was confirmed that over-expression of miR-133 reduced the protein level of KLF15, which reduced the level of the downstream target GLUT4. Cardiac myocytes infected with lenti-decoy, in which the 3'UTR with tandem sequences complementary to miR-133 was linked to the luciferase reporter gene, had decreased miR-133 levels and increased levels of GLUT4. The expression levels of KLF15 and GLUT4 were decreased at the left ventricular hypertrophy and congestive heart failure stage in a rat model. The present results indicated that miR-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiomyocytes.

• Publication year

  2009

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2009-11-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbrc.2009.08.136PMID 19720047
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet.

  2008cited by this paper
• microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart.

  2008cited by this paper
• TG-interacting factor is required for the differentiation of preadipocytes This study was supported in part by grants (T.K., K.H., K.O.) from the Ministry of Education, Culture, Science, Sports, and Technology of Japan. Published, JLR Papers in Press, February 28, 2008.

  2008cited by this paper
• Oxidative stress induces GLUT4 translocation by activation of PI3‐K/Akt and dual AMPK kinase in cardiac myocytes

  2008influential reference
• Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy

  2007cited by this paper
• MicroRNAs Play an Essential Role in the Development of Cardiac Hypertrophy

  2007cited by this paper
• MicroRNA-133 controls cardiac hypertrophy

  2007cited by this paper
• The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation

  2006cited by this paper
• A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure

  2006cited by this paper
• MicroRNAs: a new class of regulatory genes affecting metabolism.

  2006cited by this paper
• Myocardial substrate metabolism in the normal and failing heart.

  2005cited by this paper
• Energy metabolism in heart failure

  2004cited by this paper
• Insulin Signalling and Resistance in Patients with Chronic Heart Failure

  2003cited by this paper
• The Krüppel-like Factor KLF15 Regulates the Insulin-sensitive Glucose Transporter GLUT4*

  2002cited by this paper
• The Endosomal Compartment Is an Insulin-Sensitive Recruitment Site for GLUT4 and GLUT1 Glucose Transporters in Cardiac Myocytes.

  2001cited by this paper
• Chronic Phosphocreatine Depletion by the Creatine Analogue &bgr;-Guanidinopropionate Is Associated With Increased Mortality and Loss of ATP in Rats After Myocardial Infarction

  2001cited by this paper
• Responses of GLUT4-Deficient Hearts to Ischemia Underscore the Importance of Glycolysis

  2001cited by this paper
• Mitochondrial pathology in cardiac failure.

  2001cited by this paper
• The endosomal compartment is an insulin-sensitive recruitment site for GLUT4 and GLUT1 glucose transporters in cardiac myocytes.

  2001cited by this paper
• GLUT4 Gene Regulation and Manipulation*

  1999cited by this paper
• Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus.

  1999cited by this paper
• Upregulated expression of cardiac endothelin-1 participates in myocardial cell growth in Bio14.6 Syrian cardiomyopathic hamsters.

  1999cited by this paper
• Insulin resistance in patients with cardiac hypertrophy.

  1999cited by this paper
• Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes.

  1998cited by this paper
• Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

  1997cited by this paper
• Insulin-induced Recruitment of Glucose Transporter 4 (GLUT4) and GLUT1 in Isolated Rat Cardiac Myocytes

  1997cited by this paper
• Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.

  1996cited by this paper
• Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved.

  1996cited by this paper
• The metabolic consequences of altered glucose transporter expression in transgenic mice

  1996cited by this paper
• Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats.

  1994cited by this paper
• Regulation of the GLUT4/muscle-fat glucose transporter mRNA in adipose tissue of insulin-deficient diabetic rats.

  1993cited by this paper
• 31P Magnetic Resonance Spectroscopy in Dilated Cardiomyopathy and Coronary Artery Disease: Altered Cardiac High‐Energy Phosphate Metabolism in Heart Failure

  1992cited by this paper
• Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure.

  1991cited by this paper

• MicroRNAs in type 2 diabetes mellitus and its cardiovascular complications: mechanistic insights and translational potential.

  2026cites this paper
• MicroRNAs in Heart Failure Pathogenesis and Progression: Mechanistic Control, Biomarker Potential, and Translational Perspectives

  2026cites this paper
• Biochemical study on microRNAs (miR-410, miR-133 and miR-582) in Egyptian type 1 diabetic patients

  2025cites this paper
• Biological Roles of Selected microRNAs in Glucose Metabolism as a Candidate Biomarker for Diabetes Mellitus

  2025cites this paper
• Extracellular fluid miRNAs in PCOS.

  2025cites this paper
• The expression profiles and roles of microRNAs in cardiac glucose metabolism

  2025cites this paper
• Metabolic-epigenetic interactions in heart failure: Current understanding and future directions.

  2025cites this paper
• Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease

  2025cites this paper
• Deciphering the multifaceted role of microRNAs in hepatocellular carcinoma: Integrating literature review and bioinformatics analysis for therapeutic insights

  2024cites this paper
• Dietary modulation of microRNAs in insulin resistance and type 2 diabetes.

  2024cites this paper
• Advances in the interaction of glycolytic reprogramming with lactylation.

  2024cites this paper
• Comparative effects of metformin and varying intensities of exercise on miR-133a expression in diabetic rats: Insights from machine learning analysis

  2024cites this paper
• MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology

  2023cites this paper
• Glucose transporter 4: Insulin response mastermind, glycolysis catalyst and treatment direction for cancer progression.

  2023cites this paper
• The Involvement of Krüppel-like Factors in Cardiovascular Diseases

  2023cites this paper
• Diabetes and associated cardiovascular complications: The role of microRNAs

  2023cites this paper
• Regulation and mechanism of action of miRNAs on insulin resistance in skeletal muscles

  2023cites this paper
• miRNA contributes to neuropathic pains.

  2023cites this paper
• Exercise increases MEF2A abundance in rat cardiac muscle by downregulating microRNA-223-5p

  2023cites this paper
• Contribution of skeletal muscle-specific microRNA-133b to insulin resistance in heart failure.

  2023cites this paper
• Differential Expression of Adipocyte and Myotube Extracellular Vesicle miRNA Cargo in Chronic Binge Alcohol-administered SIV-infected Male Macaques.

  2022cites this paper
• Eight weeks of combined exercise training do not alter circulating microRNAs-29a, -133a, -133b, and -155 in young, healthy men

  2022influential citation
• Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases

  2022cites this paper
• The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside—A Systematic Literature Review

  2022cites this paper
• The Protective Effects of Neurotrophins and MicroRNA in Diabetic Retinopathy, Nephropathy and Heart Failure via Regulating Endothelial Function

  2022cites this paper
• Cardiac Metabolism and MiRNA Interference

  2022cites this paper
• Palmitic acid declines glucose uptake in HepG2 cells via modulating phosphoglucomutase 1 to repress phosphatidylinositol 3 kinase/protein kinase B and JNK pathways via inducing microRNA-124-3p

  2022influential citation
• Role of microRNAs in regulation of insulin secretion and insulin signaling involved in type 2 diabetes mellitus

  2022cites this paper
• Association of Genetic Polymorphisms in MicroRNAs With Type 2 Diabetes Mellitus in a Chinese Population

  2021cites this paper
• Roles of MicroRNAs in Glucose and Lipid Metabolism in the Heart

  2021cites this paper
• Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy

  2021cites this paper
• Knockdown circular RNA circGFRA1 inhibits glioma cell proliferation and migration by upregulating microRNA-99a

  2021cites this paper
• Epigenetics in hepatocellular carcinoma.

  2021cites this paper
• Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic Cardiomyopathy

  2021cites this paper
• Unique Circulating MicroRNA Associations with Dysglycemia in People Living with HIV and Alcohol Use.

  2021cites this paper
• RGD-PEG-PLA Delivers MiR-133 to Infarct Lesions of Acute Myocardial Infarction Model Rats for Cardiac Protection

  2020cites this paper
• Potential roles of microRNA-1 and microRNA-133 in cardiovascular disease.

  2020cites this paper
• The pivotal role of MicroRNAs in glucose metabolism in cancer.

  2020cites this paper
• Potential Roles of MyomiRs in Cardiac Development and Related Diseases

  2020cites this paper
• Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect

  2020cites this paper
• LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15

  2020cites this paper
• Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma

  2020cites this paper
• Non-coding RNAs: the new central dogma of cancer biology

  2020cites this paper
• Multiple roles of KLF15 in the heart: Underlying mechanisms and therapeutic implications.

  2019cites this paper
• Post-transcriptional markers associated with clinical complications in Type 1 and Type 2 diabetes mellitus.

  2019cites this paper
• Ergot Alkaloid Exposure During Gestation Alters: 3. Fetal Growth, Muscle Fiber Development and miRNA Transcriptome.

  2019cites this paper
• Celastrol Reverses Palmitic Acid-Induced Insulin Resistance in HepG2 Cells via Restoring the miR-223 and GLUT4 Pathway.

  2019cites this paper
• miR-15a/-16 Inhibit Angiogenesis by Targeting the Tie2 Coding Sequence: Therapeutic Potential of a miR-15a/16 Decoy System in Limb Ischemia

  2019cites this paper
• Tumorigenesis and Metabolism Disorder

  2019cites this paper
• MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities

  2019cites this paper
• The Predominant microRNAs in β-cell Clusters for Insulin Regulation and Diabetic Control.

  2019cites this paper
• The role of microRNAs in the regulation of insulin signaling pathway with respect to metabolic and mitogenic cascades: A review

  2019cites this paper
• Explorer miR-15 a /-16 Inhibit Angiogenesis by Targeting the Tie 2 Coding Sequence : Therapeutic Potential of a miR-15 a / 16 Decoy System in Limb Ischemia

  2019cites this paper
• Diabetes and Heart Failure: Pathogenesis and Novel Therapeutic Approaches

  2019cites this paper
• Association of single nucleotide polymorphisms of miRNAs involved in the GLUT4 pathway in T2DM in a Chinese population

  2019cites this paper
• Mechanisms of statin‐induced new‐onset diabetes

  2019cites this paper
• Progesterone-induced miR-152 interferes with embryonic implantation by downregulating GLUT3 in endometrial epithelium.

  2019cites this paper
• The diagnostic value of circulating microRNAs in heart failure

  2019cites this paper
• Micromanaging aerobic respiration and glycolysis in cancer cells

  2019cites this paper
• Effect of chronic consumption of pistachios (Pistacia vera L.) on glucose metabolism in pre-diabetics and type 2 diabetics: A systematic review

  2019cites this paper
• The Melanocortin MC5R as a New Target for Treatment of High Glucose-Induced Hypertrophy of the Cardiac H9c2 Cells

  2018cites this paper
• Expressing MicroRNA Bantam Sponge Drastically Improves the Insecticidal Activity of Baculovirus via Increasing the Level of Ecdysteroid Hormone in Spodoptera exigua Larvae

  2018cites this paper
• HIF-1, Metabolism, and Diabetes in the Embryonic and Adult Heart

  2018cites this paper
• Downregulation of microRNA-1 attenuates glucose-induced apoptosis by regulating the liver X receptor α in cardiomyocytes

  2018cites this paper
• MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment.

  2018cites this paper
• Deciphering Non-coding RNAs in Cardiovascular Health and Disease

  2018cites this paper
• Downregulation of miR‐33b promotes non‐small cell lung cancer cell growth through reprogramming glucose metabolism miR‐33b regulates non‐small cell lung cancer cell growth

  2018cites this paper
• Exercise Training-Induced Changes in MicroRNAs: Beneficial Regulatory Effects in Hypertension, Type 2 Diabetes, and Obesity

  2018cites this paper
• T Cell Metabolism in Autoimmune Diseases

  2018cites this paper
• Characterization of miRNA profiles in the mammary tissue of dairy cattle in response to heat stress

  2018cites this paper
• Alteration in cardiac PI3K/Akt/mTOR and ERK signaling pathways with the use of growth hormone and swimming, and the roles of miR21 and miR133

  2018cites this paper
• ER stress mediated regulation of miR23a confer Hela cells better adaptability to utilize glycolytic pathway

  2018cites this paper
• Kruppel-Like Factor 15 Is Critical for the Development of Left Ventricular Hypertrophy

  2018cites this paper
• The interplay between noncoding RNAs and insulin in diabetes.

  2018cites this paper
• miRNA in tumour metabolism and why could it be the preferred pathway for energy reprograming

  2018cites this paper
• Emerging Actors in Diabetic Cardiomyopathy: Heartbreaker Biomarkers or Therapeutic Targets?

  2018cites this paper
• Novel molecular regulators of adipose tissue metabolism

  2018cites this paper
• Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides

  2018cites this paper
• The Destiny of Glucose from a MicroRNA Perspective

  2018cites this paper
• Gene expression and gene associations during the development of heart failure with preserved ejection fraction in the Dahl salt sensitive model of hypertension

  2018cites this paper
• miR-133a function in the pathogenesis of dedifferentiated liposarcoma

  2018cites this paper
• MicroRNA-133 mediates cardiac diseases: Mechanisms and clinical implications.

  2017cites this paper
• Diabetic Cardiomyopathy: An Immunometabolic Perspective

  2017influential citation
• KLF15 protects against isoproterenol-induced cardiac hypertrophy via regulation of cell death and inhibition of Akt/mTOR signaling.

  2017cites this paper
• Diagnostic approaches for diabetic cardiomyopathy

  2017cites this paper
• MicroRNAs-Mediated Regulation of Skeletal Muscle GLUT4 Expression and Translocation in Insulin Resistance

  2017cites this paper
• MiR-29b inhibits the growth of glioma via MYCN dependent way

  2017cites this paper
• Recent Advances on the Role of microRNAs in both Insulin Resistance and Cancer.

  2017cites this paper
• Applications of Extracellular RNAs in Oncology

  2017cites this paper
• The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis

  2017cites this paper
• MiRNA Deregulation in Cardiac Aging and Associated Disorders.

  2017cites this paper
• Role of biomarkers in predicting diabetes complications with special reference to diabetic foot ulcers.

  2017cites this paper
• Pathological Effects of Exosomes in Mediating Diabetic Cardiomyopathy.

  2017cites this paper
• MicroRNAs and altered metabolism of clear cell renal cell carcinoma: Potential role as aerobic glycolysis biomarkers.

  2017cites this paper
• Exercise and adipose tissue GLUT4

  2017cites this paper
• MicroRNA regulation and analytical methods in cancer cell metabolism

  2017cites this paper
• Bioinformatics in MicroRNA Research

  2017cites this paper
• Involvement of MicroRNAs in Diabetes and Its Complications.

  2017cites this paper
• İyi Bilinen Kardiyovasküler Hastalıkların Bilinmeyen Yönleri; Yeni Tanımlanmış miRNA Genleri

  2016cites this paper
• Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects

  2016cites this paper